Related Experiment Video
Updated: Aug 8, 2026
A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes
Published on: March 25, 2014
Measurement of Peptide Binding to MHC Class II Molecules by Fluorescence Polarization
Liusong Yin1, Lawrence J Stern1,2
1Department of Pathology, University of Massachusetts Medical School, Worcester, Massachusetts.
Insights
A new fluorescence polarization assay quantifies peptide binding to major histocompatibility complex class II (MHCII) molecules. This method enables rapid, high-throughput screening of peptide-MHCII interactions for epitope selection.
Area of Science:
- Immunology
- Molecular Biology
- Biochemistry
Background:
- Peptide binding to major histocompatibility complex class II (MHCII) molecules is crucial for adaptive immunity, dictating T cell responses.
- Understanding these interactions is key for vaccine development and autoimmune disease research.
- Current methods for assessing peptide-MHCII binding can be time-consuming and low-throughput.
Purpose of the Study:
- To develop and validate a simple, rapid, and high-throughput fluorescence polarization-based binding competition assay.
- To accurately measure the binding affinity of various peptides to soluble recombinant MHCII molecules.
- To provide a robust method for characterizing peptide-MHCII interactions for CD4+ T cell epitope selection.
Main Methods:
- A fluorescence polarization (FP) assay was established using soluble recombinant MHCII molecules and a fluorescence-labeled probe peptide.
- The binding competition assay measures the ability of unlabeled peptides to inhibit the binding of the labeled probe.
- Peptide labeling was performed using an amine-reactive fluorescent probe, with data analysis for IC50 determination discussed.
Main Results:
- The developed FP assay effectively measures peptide binding to MHCII molecules.
- The assay allows for the characterization of binding strength via IC50 values.
- The protocol facilitates simple, fast, and high-throughput measurements for a large number of peptides.
Conclusions:
- This fluorescence polarization assay offers a powerful and efficient tool for studying peptide-MHCII interactions.
- The method supports high-throughput screening, accelerating the identification of T cell epitopes.
- This assay is valuable for research in immunology, vaccinology, and the study of immune-mediated diseases.
Abstract:
Peptide binding to major histocompatibility complex class II (MHCII) molecules is a key process in antigen presentation and CD4+ T cell epitope selection. This unit describes a fairly simple but powerful fluorescence polarization-based binding competition assay to measure peptide binding to soluble recombinant MHCII molecules. The binding of a peptide of interest to MHCII molecules is assessed based on its ability to inhibit the binding of a fluorescence-labeled probe peptide, with the strength of binding characterized as IC50 (concentration required for 50% inhibition of probe peptide binding). Data analysis related to this method is discussed. In addition, this unit includes a support protocol for fluorescence labeling peptide using an amine-reactive probe. The advantage of this protocol is that it allows simple, fast, and high-throughput measurements of binding for a large set of peptides to MHCII molecules.
